A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

Moustafa Moustafa,1 Lawrence Lehrner,2 Fahd Al-Saghir,3 Mark Smith,4 Sunita Goyal,5 Maureen Dillon,5 John Hunter,5 Randy Holmes-Farley5 1South Carolina Nephrology and Hypertension Center Inc., Orangeburg, SC, USA; 2Kidney Specialists of Southern Nevada, Las Vegas, NV, USA; 3Michigan Kidney Consultan...

Full description

Bibliographic Details
Main Authors: Moustafa M, Lehrner L, Al-Saghir F, Smith M, Goyal S, Dillon M, Hunter J, Holmes-Farley R
Format: Article
Language:English
Published: Dove Medical Press 2014-04-01
Series:International Journal of Nephrology and Renovascular Disease
Online Access:http://www.dovepress.com/a-randomized-double-blind-placebo-controlled-dose-ranging-study-using--a16392

Internet

http://www.dovepress.com/a-randomized-double-blind-placebo-controlled-dose-ranging-study-using--a16392

Similar Items